BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23877653)

  • 1. Assessment of (18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the preoperative management of patients with gastric cancer.
    Namikawa T; Okabayshi T; Nogami M; Ogawa Y; Kobayashi M; Hanazaki K
    Int J Clin Oncol; 2014 Aug; 19(4):649-55. PubMed ID: 23877653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
    Chen J; Cheong JH; Yun MJ; Kim J; Lim JS; Hyung WJ; Noh SH
    Cancer; 2005 Jun; 103(11):2383-90. PubMed ID: 15856477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative prediction of the pathological stage of advanced gastric cancer by
    Yamada K; Urakawa N; Kanaji S; Hasegawa H; Yamamoto M; Yamashita K; Matsuda T; Oshikiri T; Suzuki S; Kakeji Y
    Sci Rep; 2022 Jul; 12(1):11370. PubMed ID: 35790785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Preoperative PET-CT in the Prediction of Pathological Stage of Gastric Cancer.
    Kudou M; Kosuga T; Kubota T; Okamoto K; Komatsu S; Shoda K; Konishi H; Shiozaki A; Fujiwara H; Arita T; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Otsuji E
    Ann Surg Oncol; 2018 Jun; 25(6):1633-1639. PubMed ID: 29626306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical value of 18F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography for predicting regional lymph node metastasis and non-curative surgery in primary gastric carcinoma.
    Choi JY; Shim KN; Kim SE; Jung HK; Jung SA; Yoo K
    Korean J Gastroenterol; 2014 Dec; 64(6):340-7. PubMed ID: 25530585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.
    Mochiki E; Kuwano H; Katoh H; Asao T; Oriuchi N; Endo K
    World J Surg; 2004 Mar; 28(3):247-53. PubMed ID: 14961197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
    Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
    J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and
    Vind-Kezunovic S; Bouchelouche K; Ipsen P; Høyer S; Bell C; Bjerggaard Jensen J
    Eur Urol Focus; 2019 Jan; 5(1):90-96. PubMed ID: 28753817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of
    Girard A; Rouanne M; Taconet S; Radulescu C; Neuzillet Y; Girma A; Beaufrere A; Lebret T; Le Stanc E; Grellier JF
    Eur Radiol; 2019 Aug; 29(8):4286-4293. PubMed ID: 30666449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
    Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
    Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
    Smyth E; Schöder H; Strong VE; Capanu M; Kelsen DP; Coit DG; Shah MA
    Cancer; 2012 Nov; 118(22):5481-8. PubMed ID: 22549558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical usefulness of F-18 FDG PET in lymphoepithelioma-like gastric carcinoma.
    Park S; Lee D; Lee KM; Han SU; Lee JH; Lee SJ; An YS; Yoon JK
    Eur J Radiol; 2017 Sep; 94():160-166. PubMed ID: 28712702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer.
    Oh HH; Lee SE; Choi IS; Choi WJ; Yoon DS; Min HS; Ra YM; Moon JI; Kang YH
    J Surg Oncol; 2011 Oct; 104(5):530-3. PubMed ID: 21618250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Role of the Number of 18F-FDG-Positive Lymph Nodes Detected by PET/CT for Pre-Treatment Evaluation of Locally Advanced Gastric Cancer.
    Wang X; Wei Y; Xue Y; Lu P; Yu L; Shen B
    PLoS One; 2016; 11(12):e0166836. PubMed ID: 27936109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
    Sasaki K; Kawasaki H; Sato M; Koyama K; Yoshimi F; Nagai H
    Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by 18F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer.
    Song BI; Kim HW; Won KS; Ryu SW; Sohn SS; Kang YN
    Medicine (Baltimore); 2015 Jul; 94(26):e1037. PubMed ID: 26131811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer.
    Ozawa Y; Hara M; Sakurai K; Nakagawa M; Tamaki T; Nishio M; Shibamoto Y
    Acta Radiol; 2010 Mar; 51(2):150-5. PubMed ID: 20092375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography.
    Altini C; Niccoli Asabella A; Di Palo A; Fanelli M; Ferrari C; Moschetta M; Rubini G
    Medicine (Baltimore); 2015 May; 94(20):e864. PubMed ID: 25997066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
    Kawanaka Y; Kitajima K; Fukushima K; Mouri M; Doi H; Oshima T; Niwa H; Kaibe N; Sasako M; Tomita T; Miwa H; Hirota S
    Eur J Radiol; 2016 May; 85(5):989-95. PubMed ID: 27130061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.